Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Tempest Therapeutics

    Client Virtual Booth

    TEMPEST THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Tempest Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    7000 Shoreline Court Suite 275 South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tempesttx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tempesttx
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2024/04/26/2870731/0/en/Tempest-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    26 Apr 2024
    Share Share
    Tempest Reports Data for TPST-1120 in RCC at the AACR Annual Meeting
    Tempest Reports Data for TPST-1120 in RCC at the AACR Annual Meeting

    https://www.globenewswire.com/news-release/2024/04/09/2859912/0/en/Tempest-Reports-New-Preclinical-Data-for-TPST-1120-in-RCC-at-the-AACR-Annual-Meeting.html

    GLOBENEWSWIRE
    09 Apr 2024
    Share Share
    Tempest Announces Publication of Data from Ph 1 Trial of TPST-1120 in Journal
    Tempest Announces Publication of Data from Ph 1 Trial of TPST-1120 in Journal

    https://www.globenewswire.com/news-release/2024/04/04/2857718/0/en/Tempest-Announces-Publication-of-Positive-Data-from-Phase-1-Trial-of-TPST-1120-in-Patients-with-Advanced-Solid-Tumors-in-Journal-of-Cancer-Research-Communications.html

    GLOBENEWSWIRE
    04 Apr 2024
    Share Share
    Tempest Reports Year End 2023 Financial Results and Provides Business Update
    Tempest Reports Year End 2023 Financial Results and Provides Business Update

    https://www.globenewswire.com/news-release/2024/03/19/2848979/0/en/Tempest-Reports-Year-End-2023-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    19 Mar 2024
    Share Share
    Tempest Presents New Data at the SITC 2024
    Tempest Presents New Data at the SITC 2024

    https://www.globenewswire.com//news-release/2024/03/12/2844489/0/en/Tempest-Presents-New-Data-at-the-SITC-2024-Spring-Scientific-Meeting-Supporting-Potent-Anti-tumor-Activity-of-TPST-1120-in-Multiple-Cancer-Types.html

    GLOBENEWSWIRE
    12 Mar 2024
    Share Share
    Tempest Announces Upcoming Presentation of Preclinical Data for TPST-1120
    Tempest Announces Upcoming Presentation of Preclinical Data for TPST-1120

    https://www.globenewswire.com//news-release/2024/03/05/2840933/0/en/Tempest-Announces-Upcoming-Presentation-of-Preclinical-Data-for-TPST-1120-in-Renal-Cell-Carcinoma-at-the-AACR-Annual-Meeting.html

    GLOBENEWSWIRE
    05 Mar 2024
    Share Share
    Tempest to Present at the 44th Annual TD Cowen Healthcare Conference
    Tempest to Present at the 44th Annual TD Cowen Healthcare Conference

    https://www.globenewswire.com//news-release/2024/02/26/2835099/0/en/Tempest-to-Present-at-the-44th-Annual-TD-Cowen-Healthcare-Conference.html

    GLOBENEWSWIRE
    26 Feb 2024
    Share Share
    Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com//news-release/2024/02/02/2823065/0/en/Tempest-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    02 Feb 2024
    Share Share
    Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com//news-release/2024/01/05/2804871/0/en/Tempest-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    05 Jan 2024
    Share Share
    Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com//news-release/2023/12/01/2789543/0/en/Tempest-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    01 Dec 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search